In the first week of September, the pharmaceutical company AstraZeneca, which is developing a Covid-19 vaccine in collaboration with the University of Oxford, halted the trial process when two participants who participated in a trial developed an adverse impact. After this, the trial was stopped in other countries, raising concerns …
Read More »Paris under curfew as Europe tightens virus restrictions Trump’s teenage son contracted virus, first lady reveals
In Spain, bars and restaurants will close throughout the northeast region of Catalonia for the next 15 days, as the country faces one of the highest infection rates in the European Union, with almost 900,000 cases and more than 33,000 deaths. The measures also went into effect in the Netherlands, …
Read More »Covid-19: what you need to know today
Johnson & Johnson has stopped the trial of its coronavirus vaccine candidate after an unexplained illness in one of the participants, although it was not immediately clear whether the person was part of the trial (or experimental group) receiving the injection, or the control group that does not (people in …
Read More »Coronavirus LIVE Updates: India’s Covid 19 Count Crosses 63 Lakh Mark With Peak Over 86,000 New Cases; Moderna’s Covid 19 take will not be ready for US elections
Meanwhile, the US Food and Drug Administration has expanded its investigation of a serious illness into the AstraZeneca Plc Covid-19 vaccine study and will analyze data from previous trials of similar vaccines developed by the same scientists, three sources familiar with the details told Reuters. The large late-stage American trial …
Read More »Coronavirus Vaccine: From Covaxin to Russian Vaccine Launch, Here Are All Updates on COVID-19 Vaccine Development
Amid controversy and news of accelerated trials abroad, the latest report on Sputnik V suggests that the vaccine may meet its promised target and offers tolerable immunity after the first injection. Alexander Gintsburg, director of Moscow’s Gamaleya state research institute, which runs the trials, said that enough samples have been …
Read More »Coronavirus Vaccine: 7 Participants Disqualified From Oxford Phase III Trials, Here Are Factors Considered
However, while some groups are falling ‘short’ on volunteers, others are not accepted into phase III trials. Oxford-AstraZeneca, which is one of the most promising candidate vaccines, is running phase III trials in India as ‘Covishield’. While the tests are receiving an active response from the public, recent reports have …
Read More »Phase 3 human clinical trial of Oxford vaccine begins in Pune
The phase III human clinical trial of the Covid-19 vaccine being developed by the University of Oxford and manufactured by the Serum Institute of India (SII), began at the state-run Sassoon General Hospital here in Maharashtra, El Monday, a senior official said. . “We have started phase III trials of …
Read More »India’s Covid-19 count crosses the 54 Lakh mark with a peak of more than 92,000 new cases; Sec 144 enforced in Jaipur, Jodhpur
A health worker takes a woman’s temperature in Gujarat. (Reuters) Coronavirus LIVE Updates: Concerned about the growing number of coronavirus cases, the Rajasthan government decided on Saturday night to impose Section 144 of the CrPC in 11 districts of the state. News18.com Last update: September 20, 2020 9:51 AM M. …
Read More »Coronavirus Vaccine | Latest update of the Covid-19 vaccine: the effectiveness of the Moderna vaccine will be known in November
By: Desk Explained | Pune | Updated: September 19, 2020 6:34:45 pm A research associate transfers medium to cells in the laboratory of Imperial College London. (AP Photo: Kirsty Wigglesworth) Coronavirus Vaccine Tracker: The American biotech company Moderna has said it will learn of the effectiveness of its coronavirus vaccine …
Read More »Oxford and AstraZeneca to Resume Coronavirus Vaccine Trial: Why It Matters
The University of Oxford, one of the leading Covid-19 vaccine developers in the world race, resumed its trial to test the drug it is developing with pharmaceutical company AstraZeneca on Saturday. The restart to demonstrate the drug’s effectiveness comes two days after he had to stop the trial after a …
Read More »